Skip to main content
. 2020 Apr 30;7:78. doi: 10.3389/fcvm.2020.00078

Figure 1.

Figure 1

The balance between ACE and ACE2 in COVID-19. (A) Treatment with ACEI or ARB increases the expression of cardiac ACE2 and could further increase the risk of coronavirus infection. (B) Coronavirus infection can downregulate ACE2, further activate the RAAS system and increase the cardiovascular burden. ACE, angiotensin-converting enzyme; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; RAAS, renin-angiotensin-aldosterone system.